An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
Conditions: Systemic Lupus Erythematosus; Systemic Sclerosis; Inflammatory Myopathy; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiphospholipid Syndrome; Sjogren ' s Syndrome Interventions: Other: YTS109 Sponsors: China Immunotech (Beijing) Biotechnology Co., Ltd.; Shanghai Changzheng Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease
Conditions: Systemic Lupus Erythematosus (SLE); Sjogren ' s Syndrome; Systemic Sclerosis; Inflammatory Myopathy; ANCA Associated Vasculitis; Antiphospholipid Syndrome Interventions: Biological: Anti-CD19-CD3E-CAR-T cells Sponsors: Shanghai Changzheng Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye
Conditions: Sjogren ' s Syndrome; Dry Eye; Neurotrophic Keratitis Interventions: Diagnostic Test: Eye Exam Sponsors: Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Assessing the Efficacy of a Hydrogen Peroxide Mouthwash for Oral Wound Healing, Oral Hygiene and Xerostomia Relief
Conditions: Wound Heal; Oral Dryness; Postoperative Pain; Sjogren ' s Syndrome; Biopsy Wound; Mouth; Wound; Mouth Dryness; Dental Plaque; Gingival Inflammation Interventions: Device: Hydrogen Carbamide/Peroxide Mouthwash; Device: Placebo mouthwash Sponsors: National and Kapodistrian University of Athens; Ioulia And Irene Tseti Pharmaceutical Laboratories S.A. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus; Lupus Nephritis; Autoimmune Diseases; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Granulomatous Polyangiitis; Microscopic Polyangiitis; Systemic Sclerosis; Idiopathic Inflammatory Myopathies; Sjogren ' s Syndrome Interventions: Biological: CD19- BCMA CAR-T cells Sponsors: Essen Biotech Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Rheumatology Diet Study
Conditions: Diet Habit; Rheumatologic Disease; Autoimmune Diseases; Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Dermatomyositis/Polymyositis; Sjogren ' s Syndrome; Systemic Lupus Erythematous; Scleroderma; Fibromyalgia Sponsors: University of Central Florida Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Ultra-High Frequency Ultrasonography in Sj ögren's Syndrome
Conditions: Sjogren ' s Syndrome Interventions: Other: Ultra-High Frequency Ultrasound scan of minor salivary glands Sponsors: University of Pisa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Ro60 Expression in Macrophages in Sjogren's Disease
Conditions: Sjogren ' s Syndrome Interventions: Diagnostic Test: Positive serology for anti-SSA Sponsors: Centre Hospitalier Universitaire de Nice Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
EVADRY ® in the Treatment of Xerostomia in Sjögren's Syndrome
Conditions: Sjogren ' s Syndrome Interventions: Dietary Supplement: EVADRY; Other: Placebo Sponsors: University Tunis El Manar Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome
Conditions: Sjogren ' s Syndrome Interventions: Drug: HZN-1116; Drug: Placebo Sponsors: Horizon Therapeutics Ireland DAC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
R-2487 in Patients With Sjogren's Syndrome (SS)
Conditions: Sjogren ' s Syndrome; Sj ögren; Sjögren Syndrome, Unspecified Interventions: Drug: R-2487 Sponsors: Rise Therapeutics LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sj ögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity
Conditions: Sjogren ' s Syndrome Interventions: Drug: Dazodalibep; Drug: Placebo Sponsors: Horizon Therapeutics Ireland DAC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
Conditions: SLE (Systemic Lupus); Sjogren ' s Syndrome; Systemic Scleroderma; Dermatomyositis; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Interventions: Biological: CD19 targeted CAR-T cells Sponsors: Chongqing Precision Biotech Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.
Condition: Sjogrens Syndrome Interventions: Drug: Ianalumab (VAY736); Other: Placebo Sponsor: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
